NCT07373015

Brief Summary

The aim of this study is evaluating and safety and efficacy between the modified double snare EMR and ESD. It is intended to prove that for rectal neuroendocrine tumors within 1 cm, the complete resection rate of the mDS-EMR is not inferior to that of ESD, but may with shorter operation time, lower complication rate and lower treatment cost.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
118

participants targeted

Target at P50-P75 for not_applicable

Timeline
26mo left

Started Jan 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Jan 2026Jun 2028

Study Start

First participant enrolled

January 1, 2026

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

January 9, 2026

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 28, 2026

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2028

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2028

Last Updated

January 28, 2026

Status Verified

December 1, 2025

Enrollment Period

2.4 years

First QC Date

January 9, 2026

Last Update Submit

January 22, 2026

Conditions

Keywords

Endoscopic Submucosal DissectionEndoscopic Mucosal Resectionrectal neuroendocrine tumor

Outcome Measures

Primary Outcomes (1)

  • complete resection

    Rate of complete en bloc resection with microscopically negative margins.

    Day 30

Secondary Outcomes (6)

  • En bloc resection

    Day 30

  • operation success rate

    Periprocedural

  • operation time

    Periprocedural

  • Postoperative hospital stay

    through study completion, an average of 30 days

  • operation-related expenses

    through study completion, an average of 30 days

  • +1 more secondary outcomes

Other Outcomes (4)

  • Delayed perforation

    30 days after the operation

  • Delayed bleeding

    30 days after the operation

  • Intraoperative bleeding

    Intraoperative

  • +1 more other outcomes

Study Arms (2)

ESD

ACTIVE COMPARATOR

The traditional ESD treatment method is adopted, which includes submucosal injection of normal saline and methylene blue suspension, cutting and dissection by mucosal incision knife, hemostasis and cliping of the wound. Traction is allowed during the operation.

Procedure: endoscopic submucosal dissection

mDS-EMR

EXPERIMENTAL

Modified double snare assisted EMR was used for treatment. Put the first snare for resecting outside the endoscope body. Then put the second snare at the base through the channel to tighten the lesion. Finally, place the first snare below the second one to tighten the lesion and perform electrically-assisted removal. Then, metal clips will be used to close the wound.

Procedure: modified double snare assisted endoscopic mucosal resection

Interventions

A polypectomy snare (resection snare) was placed outside of the endoscope. After approaching the lesion, a second polypectomy snare (capture snare) was inserted through the biopsy channel of the endoscope to grasp and lift the lesion. The snare preloaded outside of the endoscope was released, passed through the capture snare and positioned below the capture snare to grasp the base of the lesion. Once the lesion was securely grasped, it was resected by resection snare to achieve en bloc resection. The wounds were closed by clips.

mDS-EMR

The procedure includes submucosal injection of normal saline and methylene blue suspension, cutting and dissection by mucosal incision knife (such as Dual knife, Golden knife or Kunpeng knife, etc.) , hemostasis and sealing of the wound. Traction is allowed during the operation.

ESD

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Typical rectal neuroendocrine tumors by endoscopy (within 15cm from the anal verge, yellowish subepithelial elevation with a smooth surface, and dilated blood vessels in some areas).
  • The maximum diameter of the lesion is smaller than 1cm by preoperative endoscopic assessment.
  • Lesion is located within the mucosal and submucosal layer by preoperative endoscopic assessment.
  • Patients can understand and sign the informed consent.

You may not qualify if:

  • Poor coagulation function(PT\>15 seconds or APTT\>45 seconds or INR\>2.0)
  • With severe cardiovascular or cerebrovascular diseases and cannot tolerate operation( with a history of stroke or myocardial infarction within the past month or with severe heart failure and cardiac function grade III)
  • Indication of metastasis by preoperative imaging examinations
  • With more than or equal to 2 rectal neuroendocrine tumors
  • With other complications that are not suitable for this study by multidisciplinary team assesment
  • Cases of recurrence after operation for neuroendocrine tumors

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Endoscopic Mucosal Resection

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2026

First Posted

January 28, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

May 31, 2028

Study Completion (Estimated)

June 30, 2028

Last Updated

January 28, 2026

Record last verified: 2025-12